help button home button Am J Pathol ASIP WHAT IS IT?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lloyd, R. V.
Right arrow Articles by Kulig, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lloyd, R. V.
Right arrow Articles by Kulig, E.

American Journal of Pathology, Vol 150, 401-407, Copyright © 1997 by American Society for Investigative Pathology


REGULAR ARTICLES

Aberrant p27kip1 expression in endocrine and other tumors

RV Lloyd, L Jin, X Qian and E Kulig
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

The p27kip1 (p27) gene encodes an inhibitor of cyclin-dependent kinase activity. The expression of p27 protein in normal and neoplastic tissues was investigated by immunoblotting and immunohistochemistry. Immunoblotting studies detected a 27-kd protein band that was decreased in neoplastic pituitary tissues compared with normal pituitary. Immunostaining of 177 tissues showed abundant expression of p27 protein in normal tissues with decreased numbers of immunoreactive cells in adenomas and carcinomas in both endocrine and nonendocrine tissues. p27 expression was inversely related to the proliferation marker Ki-67 antigen detected with monoclonal antibody MIB-1. Parathyroid adenomas and hyperplasias had similar Ki-67 labeling indices; however, hyperplasias had threefold more p27-positive cells than parathyroid adenomas, suggesting that p27 immunostaining may be useful in distinguishing between these two conditions. These results indicate that there is widespread aberrant p27 expression in hyperplastic tissues and in benign and malignant neoplasms compared with normal tissues. Immunohistochemical analysis of p27 along with Ki-67 may be used to assess the biological behavior of various neoplasms, to classify hyperplastic and neoplastic tissues, and to study cell cycle regulation during tumor progression.


This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
T. A. Milne, C. M. Hughes, R. Lloyd, Z. Yang, O. Rozenblatt-Rosen, Y. Dou, R. W. Schnepp, C. Krankel, V. A. LiVolsi, D. Gibbs, et al.
Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors
PNAS, January 18, 2005; 102(3): 749 - 754.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. H. Min, J.-W. Cheong, J. Y. Kim, J. I. Eom, S. T. Lee, J. S. Hahn, Y. W. Ko, and M. H. Lee
Cytoplasmic Mislocalization of p27Kip1 Protein Is Associated with Constitutive Phosphorylation of Akt or Protein Kinase B and Poor Prognosis in Acute Myelogenous Leukemia
Cancer Res., August 1, 2004; 64(15): 5225 - 5231.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
K. E. A. LaRue, M. Khalil, and J. P. Freyer
Microenvironmental Regulation of Proliferation in Multicellular Spheroids Is Mediated through Differential Expression of Cyclin-Dependent Kinase Inhibitors
Cancer Res., March 1, 2004; 64(5): 1621 - 1631.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. A. Ghanem, T. H. Van der Kwast, M. K. Sudaryo, R. B. Mathoera, M. M. van den Heuvel, A.-A. M. Al-Doray, R. M. Nijman, and G. J. van Steenbrugge
MIB-1 (KI-67) Proliferation Index and Cyclin-Dependent Kinase Inhibitor p27Kip1 Protein Expression in Nephroblastoma
Clin. Cancer Res., January 15, 2004; 10(2): 591 - 597.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pathol.Home page
A A Khan, P D Abel, K S Chaudhary, Z Gulzar, G W H Stamp, and E-N Lalani
Inverse correlation between high level expression of cyclin E and proliferation index in transitional cell carcinoma of the bladder
Mol. Pathol., December 1, 2003; 56(6): 353 - 361.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
T. Gelen, G. O. Elpek, N. H. Aksoy, M. Ogus, and N. Keles
p27 Labeling Index and Proliferation in Gastrointestinal Stromal Tumors: Correlations with Clinicopathologic Factors and Recurrence
Jpn. J. Clin. Oncol., July 1, 2003; 33(7): 346 - 352.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Korbonits, H. S. Chahal, G. Kaltsas, S. Jordan, Y. Urmanova, Z. Khalimova, P. E. Harris, W. E. Farrell, F.-X. Claret, and A. B. Grossman
Expression of Phosphorylated p27Kip1 Protein and Jun Activation Domain-Binding Protein 1 in Human Pituitary Tumors
J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2635 - 2643.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. L. C. Khoo, N. J. P. Beasley, S. Ezzat, J. L. Freeman, and S. L. Asa
Overexpression of Cyclin D1 and Underexpression of p27 Predict Lymph Node Metastases in Papillary Thyroid Carcinoma
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1814 - 1818.
[Abstract] [Full Text] [PDF]


Home page
Arch Otolaryngol Head Neck SurgHome page
M. L. C. Khoo, J. L. Freeman, I. J. Witterick, J. C. Irish, L. E. Rotstein, P. J. Gullane, and S. L. Asa
Underexpression of p27/Kip in Thyroid Papillary Microcarcinomas With Gross Metastatic Disease
Arch Otolaryngol Head Neck Surg, March 1, 2002; 128(3): 253 - 257.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
W. Liu, S. L. Asa, I. G. Fantus, P. G. Walfish, and S. Ezzat
Vitamin D Arrests Thyroid Carcinoma Cell Growth and Induces p27 Dephosphorylation and Accumulation through PTEN/Akt-Dependent and -Independent Pathways
Am. J. Pathol., February 1, 2002; 160(2): 511 - 519.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
F. Mouriaux, C.-A. Maurage, P. Labalette, B. Sablonnière, F. Malecaze, and J.-M. Darbon
Cyclin-Dependent Kinase Inhibitory Protein Expression in Human Choroidal Melanoma Tumors
Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 2837 - 2843.
[Abstract] [Full Text]


Home page
JCOHome page
A. M. Oliveira, A. G. Nascimento, S. H. Okuno, and R. V. Lloyd
p27kip1 Protein Expression Correlates With Survival in Myxoid and Round-Cell Liposarcoma
J. Clin. Oncol., August 15, 2000; 18(15): 2888 - 2893.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
C. J. Jones, D. Kipling, M. Morris, P. Hepburn, J. Skinner, A. Bounacer, F. S. Wyllie, M. Ivan, J. Bartek, D. Wynford-Thomas, et al.
Evidence for a Telomere-Independent "Clock" Limiting RAS Oncogene-Driven Proliferation of Human Thyroid Epithelial Cells
Mol. Cell. Biol., August 1, 2000; 20(15): 5690 - 5699.
[Abstract] [Full Text]


Home page
Clin. Cancer Res.Home page
L. Cheng, R. V. Lloyd, A. L. Weaver, T. M. Pisansky, J. C. Cheville, D. M. Ramnani, B. C. Leibovich, M. L. Blute, H. Zincke, and D. G. Bostwick
The Cell Cycle Inhibitors p21WAF1 and p27KIP1 Are Associated with Survival in Patients Treated by Salvage Prostatectomy after Radiation Therapy
Clin. Cancer Res., May 1, 2000; 6(5): 1896 - 1899.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Xu, T. Sano, S. Yamada, C. C. Li, and M. Hirokawa
Expression of Corticotropin-Releasing Hormone Messenger Ribonucleic Acid in Human Pituitary Corticotroph Adenomas Associated with Proliferative Potential
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 1220 - 1225.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
K. Lidhar, M. Korbonits, S. Jordan, Z. Khalimova, G. Kaltsas, X. Lu, R. N. Clayton, P. J. Jenkins, J. P. Monson, G. M. Besser, et al.
Low Expression of the Cell Cycle Inhibitor p27Kip1 in Normal Corticotroph Cells, Corticotroph Tumors, and Malignant Pituitary Tumors
J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3823 - 3830.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
C. C. R. Lee, T. Ichihara, S. Yamamoto, H. Wanibuchi, K. Sugimura, S. Wada, T. Kishimoto, and S. Fukushima
Reduced expression of the CDK inhibitor p27KIP1 in rat two-stage bladder carcinogenesis and its association with expression profiles of p21WAF1/Cip1 and p53
Carcinogenesis, September 1, 1999; 20(9): 1697 - 1708.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. G. Pestell, C. Albanese, A. T. Reutens, J. E. Segall, R. J. Lee, and A. Arnold
The Cyclins and Cyclin-Dependent Kinase Inhibitors in Hormonal Regulation of Proliferation and Differentiation
Endocr. Rev., August 1, 1999; 20(4): 501 - 534.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. Masciullo, A. Sgambato, C. Pacilio, B. Pucci, G. Ferrandina, J. Palazzo, A. Carbone, A. Cittadini, S. Mancuso, G. Scambia, et al.
Frequent Loss of Expression of the Cyclin-dependent Kinase Inhibitor p27 in Epithelial Ovarian Cancer
Cancer Res., August 1, 1999; 59(15): 3790 - 3794.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. L. M. Dahia and A. B. Grossman
The Molecular Pathogenesis of Corticotroph Tumors
Endocr. Rev., April 1, 1999; 20(2): 136 - 155.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
R. V. Lloyd, L. A. Erickson, L. Jin, E. Kulig, X. Qian, J. C. Cheville, and B. W. Scheithauer
p27kip1: A Multifunctional Cyclin-Dependent Kinase Inhibitor with Prognostic Significance in Human Cancers
Am. J. Pathol., February 1, 1999; 154(2): 313 - 323.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
E. W. Newcomb, M. Sosnow, R. I. Demopoulos, A. Zeleniuch-Jacquotte, J. Sorich, and J. L. Speyer
Expression of the Cell Cycle Inhibitor p27KIP1 Is a New Prognostic Marker Associated with Survival in Epithelial Ovarian Tumors
Am. J. Pathol., January 1, 1999; 154(1): 119 - 125.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. E. Clurman and P. Porter
New insights into the tumor suppression function of P27Kip1
PNAS, December 22, 1998; 95(26): 15158 - 15160.
[Full Text] [PDF]


Home page
Am. J. Pathol.Home page
X. Qian, L. Jin, E. Kulig, and R. V. Lloyd
DNA Methylation Regulates p27Kip1 Expression in Rodent Pituitary Cell Lines
Am. J. Pathol., November 1, 1998; 153(5): 1475 - 1482.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Nagata, K.-i. Nakayama, Y. Terada, S. Hoshi, and T. Watanabe
Cell Cycle Regulation and Differentiation in the Human Podocyte Lineage
Am. J. Pathol., November 1, 1998; 153(5): 1511 - 1520.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
H. Kawana, J.-i. Tamaru, T. Tanaka, A. Hirai, Y. Saito, M. Kitagawa, A. Mikata, K. Harigaya, and T. Kuriyama
Role of p27Kip1 and Cyclin-Dependent Kinase 2 in the Proliferation of Non-Small Cell Lung Cancer
Am. J. Pathol., August 1, 1998; 153(2): 505 - 513.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
V. A. Florenes, G. M. Mælandsmo, R. S. Kerbel, J. M. Slingerland, J. M. Nesland, and R. Holm
Protein Expression of the Cell-Cycle Inhibitor p27Kip1 in Malignant Melanoma : Inverse Correlation with Disease-Free Survival
Am. J. Pathol., July 1, 1998; 153(1): 305 - 312.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
R. Vrhovac, A. Delmer, R. Tang, J.-P. Marie, R. Zittoun, and F. Ajchenbaum-Cymbalista
Prognostic Significance of the Cell Cycle Inhibitor p27Kip1 in Chronic B-Cell Lymphocytic Leukemia
Blood, June 15, 1998; 91(12): 4694 - 4700.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Society for Investigative Pathology.